Witnessing the stock’s movement on the chart, on Thursday, Ovid Therapeutics Inc (NASDAQ: OVID) had a quiet start as it plunged -3.64% to $1.59, before settling in for the price of $1.65 at the close. Taking a more long-term approach, OVID posted a 52-week range of $0.24-$2.01.
The Healthcare sector firm’s twelve-monthly sales growth has been 24.72% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 24.72%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -29.03%. This publicly-traded company’s shares outstanding now amounts to $71.15 million, simultaneously with a float of $58.32 million. The organization now has a market capitalization sitting at $113.23 million.
Ovid Therapeutics Inc (OVID) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Ovid Therapeutics Inc’s current insider ownership accounts for 18.10%, in contrast to 87.50% institutional ownership. According to the most recent insider trade that took place on Feb 26 ’25, this organization’s President and COO sold 5,279 shares at the rate of 0.56, making the entire transaction reach 2,956 in total value, affecting insider ownership by 73,406. Preceding that transaction, on Feb 26 ’25, Company’s CBFO sold 3,902 for 0.56, making the whole transaction’s value amount to 2,185. This particular insider is now the holder of 67,973 in total.
Ovid Therapeutics Inc (OVID) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
Ovid Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -29.03% and is forecasted to reach -0.45 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -13.20% through the next 5 years, which can be compared against the 24.72% growth it accomplished over the previous five years trading on the market.
Ovid Therapeutics Inc (NASDAQ: OVID) Trading Performance Indicators
Let’s observe the current performance indicators for Ovid Therapeutics Inc (OVID). It’s Quick Ratio in the last reported quarter now stands at 4.24. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 17.13.
In the same vein, OVID’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.51, a figure that is expected to reach -0.12 in the next quarter, and analysts are predicting that it will be -0.45 at the market close of one year from today.
